Picard Medical is trading $7.90 (-10.23%) after retreating from its sharp August 24–26 rally, though the precise catalyst for the pre-market decline remains unclear.
- No new company-specific announcement dated August 28–31 was identified; the latest official release was August 19 second-quarter results.
- Those results showed stronger revenue but continued losses and potential financing needs.